Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Transplantation and Cellular Therapy
|
April 1, 2024
Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's Perspective
Rachel B Salit, Stephanie J Lee, Neel S Bhatt, et al.
Haematologica
|
November 17, 2018
Disability related to chronic graft -<i>versus</i>-host disease after alternative donor hematopoietic cell transplantation
Giancarlo Fatobene, Barry E Storer, Rachel B Salit, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2018
Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers
Jessica Liang, Stephanie J Lee, Barry E Storer, et al.
Transplantation and Cellular Therapy
|
December 9, 2022
Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies
Christina K Ullrich, Kelsey K Baker, Paul A Carpenter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies
Rachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 10, 2020
High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis
Elisabetta Xue, Hu Xie, Wendy M Leisenring, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 23, 2024
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma
Rahul Banerjee, Andrew J Cowan, Marivel Ortega, et al.
Blood Advances
|
November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase
Vikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2017
Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes
Bethany T Samuelson Bannow, Rachel B Salit, Barry E Storer, et al.
Bone Marrow Transplantation
|
May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation
Kristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Transplantation and Cellular Therapy
|
April 1, 2024
Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's Perspective
Rachel B Salit, Stephanie J Lee, Neel S Bhatt, et al.
Haematologica
|
November 17, 2018
Disability related to chronic graft -<i>versus</i>-host disease after alternative donor hematopoietic cell transplantation
Giancarlo Fatobene, Barry E Storer, Rachel B Salit, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2018
Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers
Jessica Liang, Stephanie J Lee, Barry E Storer, et al.
Transplantation and Cellular Therapy
|
December 9, 2022
Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies
Christina K Ullrich, Kelsey K Baker, Paul A Carpenter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies
Rachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 10, 2020
High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis
Elisabetta Xue, Hu Xie, Wendy M Leisenring, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 23, 2024
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma
Rahul Banerjee, Andrew J Cowan, Marivel Ortega, et al.
Blood Advances
|
November 10, 2020
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase
Vikas Gupta, James A Kennedy, Jose-Mario Capo-Chichi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2017
Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes
Bethany T Samuelson Bannow, Rachel B Salit, Barry E Storer, et al.
Bone Marrow Transplantation
|
May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation
Kristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
Page
of 5